Tobramycin and dexamethasone

DRUG2 trials

Sponsors

Bausch & Lomb Incorporated, London Vision Clinic

Conditions

BlepharitisConjunctivitisKeratitisMyopiaRefractive Errors

Phase 3

Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis

CompletedNCT01028027

Bausch & Lomb IncorporatedBlepharitis, Conjunctivitis, Keratitis

Start: 2009-10-31End: 2010-03-31Updated: 2012-02-28

Unknown Phase

VisuMax Femtosecond Laser Small Incision Lenticule Extraction for the Correction of High Myopia

CompletedNCT02528123

London Vision ClinicMyopia, Refractive Errors

Start: 2016-04-30End: 2020-12-07Updated: 2024-04-23

Related Papers

A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitis.

2012-02-0726 citations